查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942363

男性不孕症市场报告：按检测类型、治疗方法、通路、最终用户和地区划分，2026-2034 年

Male Infertility Market Report by Test Type, Treatment, Distribution Channel, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年全球男性不孕症治疗市场规模为44亿美元。 IMARC集团预测，到2034年，该市场规模将达到64亿美元，2026年至2034年的复合年增长率（CAGR）为4.28%。目前，欧洲在该市场占据领先地位。男性不孕症盛行率上升、生育年龄延迟、技术显着进步、生活方式改变、对不孕症的认识提高以及辅助生殖技术的合法化是推动市场成长的主要因素。

全球市场成长的主要驱动力是男性不孕症的增加，而男性不孕症的增加则与生活方式的改变、压力以及环境毒素的暴露有关。根据美国国家医学图书馆的报告显示，北美男性不孕症的发生率估计为4.5%至6%，而澳洲的发生率更高，约9%。东欧的发生率在8%至12%之间。 Bayasgalan等人的研究表明，只有25.6%的不孕症病例是由男性因素造成的。 Thonneau等人的另一项研究则显示，法国有20%的不孕症病例完全是由男性因素造成的。此外，基因检测和先进的精液分析等诊断技术的不断进步提高了男性不孕症的诊断准确性和早期发现率。同时，人们对不孕症治疗的认识不断提高，以及辅助生殖技术（ART）的日益普及，也推动了男性不孕症市场的成长。此外，政府的支持性政策、不断增长的医疗保健支出以及全球不孕症诊所数量的增加也促进了市场扩张。

美国作为重要的区域市场脱颖而出，其主要驱动力在于生活方式干预策略和医疗技术在解决生殖健康问题方面的广泛应用。随着人们对医疗保健的日益重视，男性越来越倾向于早期诊断和治疗不孕症。此外，公营和私营部门为意识提升而采取的措施也在推动市场需求。同时，男性不孕症研究经费的大幅增加以及肥胖和糖尿病等与不孕症相关的慢性疾病盛行率的上升，也是推动市场成长的关键因素。 2024年9月17日，韦恩州立大学接受美国国立卫生研究院（NIH）308万美元的津贴，用于研究环境因素，特别是邻苯二甲酸酯等内分泌干扰物对男性生育能力的影响。这项研究由理查德·皮尔斯纳博士领导，旨在识别与生殖结果相关的精浆生物标记物，以期改善不孕症的治疗，并加深对环境健康在生殖中所起作用的理解。此外，美国男性不孕症市场份额的扩大，也得益于专业生育诊所的普及。

男性不孕症市场趋势：

男性不孕症呈上升趋势

久坐的生活方式、环境污染以及高压力水平等多种因素共同导致男性生殖问题日益增加。根据美国心理学会（APA）预测，到2023年，十分之四点八的男性将面临较高的平均压力水平。这些因素会对精子数量、品质和活力产生负面影响。随着男性不孕症的盛行率日益受到重视，人们对精准诊断和有效治疗方法的需求也与日俱增。越来越多的夫妻寻求医疗专家的帮助来解决这些问题，导致咨询量和生育治疗服务的使用率不断上升。

延后生育的趋势日益增长

社会规范的改变和日益增长的职业抱负导致了推迟生育的显着趋势。根据美国疾病管制与预防中心（CDC）的一项调查，2015年至2019年间，40至49岁男性中有76.5%成为了父亲。然而，随着男性老龄化的增长，他们的生育能力会下降，精子品质往往会降低，DNA碎片率也会增加。这种现像也为男性带来了与老龄化相关的生育挑战。因此，男性不孕症市场正面临越来越多的老年男性对生育力保存和治疗方法的需求，他们希望在晚年建立家庭。这一趋势凸显了针对这群独特需求的专门干预措施的必要性。

重要的技术进步

精子DNA碎片化分析等创新技术使得精子品质的评估更加精细。磁激活细胞分选（MACS）等先进的精子分选方法也提高了受精成功率。这些技术提高了不孕症病因诊断的准确性，并为医疗专业人员提供了更广泛的个人化治疗方案选择。随着技术的进步，有望透过为患者提供更个人化和有效的解决方案，显着改善治疗效果，并在男性不孕症市场的发展中发挥关键作用。

辅助生殖技术（ART）的普及

辅助生殖技术（ART）在男性不孕症治疗中的应用显着增长，其中卵胞浆内单一精子注射（ICSI）已成为最有效的方法之一。 ICSI是一种体外受精（IVF）技术，可将单一精子直接注射到卵子中。即使在精子数量少、活力差或形态异常等严重的男性不孕症情况下，ICSI也能实现受精。由于其高成功率和克服自然受孕传统障碍的能力，该方法备受关注。精子采集技术的进步，包括睪丸精子提取术（TESE）和显微镜下附睪精子抽吸术（MESA），显着提高了ICSI的成功率，为无精子症患者提供了新的选择。辅助生殖技术（ART）的广泛应用和不断完善，对于面临男性不孕症挑战的夫妻来说，在拓展生育选择方面发挥着至关重要的作用。 2024 年，SpOvum 宣布推出 SpOvum ARTPT，这是一个先进的 AI 驱动平台，旨在促进辅助生殖技术 (ART) 领域的患者互动。

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章 全球男性不孕症市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按测试类型分類的市场区隔

  • 精子凝集试验
  • DNA片段化方法
  • 氧化压力分析
  • 电脑辅助精液分析
  • 精子穿透试验
  • 其他的

第七章 按治疗方法分類的市场区隔

  • 药物治疗
  • 辅助生殖技术与精索静脉曲张手术

第八章 按分销管道分類的市场细分

  • 医院药房
  • 药房和药品商店
  • 网路药房

第九章 依最终用户分類的市场细分

  • 医院和诊所
  • 不孕症治疗中心
  • 研究所
  • 其他的

第十章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章 价值链分析

第十三章 波特五力分析

第十四章：定价分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Andrology Solutions
    • CaerusBiotech
    • CinnaGen Co.
    • Ferring group of companies
    • Halotech DNA
    • Merck KGaA
    • MotilityCount
    • SCSA Diagnostics, Inc
    • Vitrolife
    • Zydus Healthcare Limited
Product Code: SR112026A6416

The global male infertility market size was valued at USD 4.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.4 Billion by 2034, exhibiting a CAGR of 4.28% during 2026-2034. Europe currently dominates the market. The rise in the prevalence of male infertility, emerging trend of delayed parenthood, notable technological advancements, changing lifestyles, increasing awareness about infertility, and legalization of assisted reproductive technologies are some of the major factors propelling the market.

The global market is driven by the rising prevalence of infertility among men due to lifestyle changes, stress, and exposure to environmental toxins. According to a report by the National Library of Medicine, it has been estimated that in North America, 4.5% to 6% of the male infertility rates are seen, whereas the rate is higher in Australia, at about 9%. In the Eastern European regions, the rate ranges between 8% and 12%. Bayasgalan et al. showed that only 25.6% of infertility cases resulted from male factors. Another study by Thonneau et al. showed that 20% of cases of infertility were due exclusively to male factors in France. Along with this, continual advancements in diagnostic technologies, such as genetic testing and advanced semen analysis, are enhancing the accuracy and early detection of male infertility. Moreover, growing awareness of fertility treatments and increasing acceptance of assisted reproductive technologies (ART) further support the male infertility market growth. Besides this, favorable government initiatives, rising healthcare spending, and the proliferation of fertility clinics globally contribute to the expansion of the market.

The United States stands out as a key regional market, primarily driven by the increasing adoption of lifestyle interventions and medical advancements tailored to address reproductive health issues. The growing emphasis on proactive healthcare is encouraging men to seek early diagnosis and treatment for infertility. Apart from this, the rise of private and public sector initiatives aimed at improving reproductive health awareness is also bolstering market demand. Furthermore, a significant increase in research funding for male infertility and the growing prevalence of chronic conditions, such as obesity and diabetes, linked to infertility, are major contributors to market growth. On 17th September 2024, Wayne State University received a USD3.08 Million NIH grant to study how environmental factors, particularly exposure to endocrine-disrupting phthalates, impact male fertility. Led by Dr. Richard Pilsner, the research focuses on identifying seminal plasma biomarkers linked to reproductive outcomes, aiming to improve fertility interventions and advance understanding of environmental health's role in reproduction. Moreover, expanding access to specialized fertility clinics enhances US male infertility market share.

Male Infertility Market Trends:

Increasing Prevalence of Male Infertility

A multitude of factors, including sedentary lifestyles, exposure to environmental pollutants, and high-stress levels, have collectively contributed to a rise in fertility issues among men. According to the American Psychological Association (APA), in 2023, 4.8 out of 10 men reported having a higher average level of stress. These factors can adversely affect sperm production, quality, and motility. As the prevalence of male infertility becomes more recognized, there is a growing demand for accurate diagnostics and effective treatment options. Couples are seeking medical expertise to address these concerns, leading to increased consultations and adoption of fertility services.

Rising Trend of Delayed Parenthood

The emerging trend of delaying parenthood gained momentum due to changing societal norms and career aspirations. According to the Centers for Disease Control and Prevention, between 2015 to 2019, 76.5% of the men aged 40-49 had fathered a child. However, advancing age is associated with a decline in male fertility, including decreased sperm quality and increased DNA fragmentation. This phenomenon has given rise to age-related fertility challenges among men. As a result, the male infertility market is witnessing a rise in demand for fertility preservation and treatment options among older men who wish to start families later in life. This trend emphasizes the need for specialized interventions that cater to the unique requirements of this demographic.

Significant Technological Advancements

Innovative techniques such as sperm DNA fragmentation analysis allow for a more detailed assessment of sperm quality. Advanced sperm selection methods, such as magnetic-activated cell sorting (MACS), also improve the possibility of successful fertilization. These technologies increase precision in identifying underlying causes of infertility and offer healthcare professionals a wider range of tools to tailor treatment plans. As technology transforms, it's likely to greatly improve results and be an important player in the growth of the male infertility market by giving patients more personalized and effective solutions.

Widespread Utilization of Assisted Reproductive Technology (ART)

The utilization of assisted reproductive technology (ART) has witnessed significant growth in addressing male infertility, with intracytoplasmic sperm injection (ICSI) emerging as one of the most effective techniques. ICSI, a specific type of in vitro fertilization (IVF), comprises the direct injection of a single sperm into an egg, facilitating fertilization even in instances of significant male factor infertility, like low sperm count, inadequate motility, or abnormal morphology. This method has gained prominence due to its high success rates and its ability to overcome barriers that previously limited natural conception. Improvements in sperm retrieval methods, including testicular sperm extraction (TESE) and microsurgical epididymal sperm aspiration (MESA), have significantly increased the success of ICSI, offering options for men experiencing azoospermia. The increasing accessibility and refinement of ART procedures are playing a pivotal role in expanding reproductive options for couples facing male infertility challenges. In 2024, SpOvum announced the launch of its advanced AI-powered platform, SpOvum ARTPT, aimed at advancing patient interaction in the field of Assisted Reproductive Technology (ART).

Male Infertility Industry Segmentation:

Analysis by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

DNA fragmentation technique stands as the largest component in 2025. DNA fragmentation testing is gaining prominence as the most popular test type in the male infertility diagnostics market due to its superior ability to assess sperm quality at a molecular level. It is different from conventional semen analysis as it examines the integrity of sperm DNA, which is essential for the successful fertilization and development of an embryo. This rising trend is due to the reliability of identifying underlying causes of infertility that standard tests may fail to detect. Growing awareness of the importance of DNA integrity among healthcare providers and patients contributes further to its market demand. Technology has also advanced, making DNA fragmentation testing more accessible and efficient.

Analysis by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Assisted reproductive technology and varicocele surgery leads the market in 2025. ART, which contains techniques such as IVF and ICSI, gives a couple the chance to overcome almost all types of fertility problems, including male-factor infertility. Success rates, among others with ART, have also made this a sought option. On the other hand, varicocele surgery has been one of the established surgical therapies for varicocele, which are dilated veins of the scrotum. The primary function of these veins will affect the production of sperm and quality due to its interference. Corrective varicocele surgery tends to enhance the flow of blood, which potentially can improve sperm motility and production. This procedure has demonstrated positive results in restoring fertility potential. The popularity of these treatments arises from their proven efficacy, leading to their prominent status in the market's landscape.

Analysis by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Hospitals pharmacies lead the market in 2025. Hospitals provide a one-stop, comprehensive facility for specialized diagnostics, medical expertise, and treatment options. This makes them the ideal destination for patients who may require comprehensive evaluation, consultations by fertility specialists, and advanced interventions, including assisted reproductive technologies (ART) and surgical procedures. They play a crucial role by providing access to prescription medications, supplements, and fertility-related products that support male reproductive health. They serve as convenient points of access for patients to obtain prescribed medications for fertility treatment and management. Additionally, they offer a discreet environment where individuals can access over-the-counter fertility supplements and products that complement treatment plans.

Analysis by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Fertility centers lead the market in 2025. These centers focus entirely on giving a comprehensive series of treatments uniquely suited to infertile men and women and to infertile couples. Fertility centers contain teams of skilled reproductive endocrinologists, urologists, and embryologists, among other experts providing diagnosis evaluations, tailor-made treatment plans, and even assisted reproductive technologies under the same roof. This is the approach, through which fertility centers operate, give an integrated kind of diagnosis, analysis, and innovative treatments for male infertility. These centers provide an ideal setting that deals with all aspects of emotional and physiological concerns related to infertility problems. The availability of current technology, latest procedures, and a complete understanding about the male reproductive health allows fertility centers to become more prominent in the choices as the most preferred option for providing guidance and achieving successful cases against male infertility.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, Europe accounted for the largest market share. The region possesses a well-developed healthcare infrastructure, including advanced medical facilities, fertility clinics, and research institutions, enabling efficient diagnosis and treatment of male infertility. The changing socio-cultural dynamics have increased awareness and acceptance of fertility issues, leading to more individuals and couples opting for medical intervention. In European countries, reproductive health is also given much importance, and comprehensive healthcare coverage is provided, thus increasing the accessibility of fertility treatments to a larger population. The ageing of the population throughout the region is also contributing to the increasing demand for ART since late parenthood is becoming prevalent. Additionally, Europe's strong presence in medical research and development (R&D) enhances innovation in male infertility treatment, which attracts patients locally and internationally seeking the best option.

Key Regional Takeaways:

United States Male Infertility Market Analysis

The male infertility market in the United States is growing due to the increasing prevalence of obesity and sedentary lifestyles, which are directly impacting sperm health and fertility. According to the Centers for Disease Control and Prevention, the prevalence of obesity among adults were 40.3% between august 2021 and 2023. Moreover, the prevalence was 39.2% among men. Additionally, fertility clinics are rapidly expanding their service portfolios, integrating advanced technologies such as microfluidic sperm sorting and AI-assisted diagnostics which is augmenting the market growth. Furthermore, health insurance companies are progressively including male infertility treatments in their coverage plans thereby increasing affordability. Similarly, the rising use of anabolic steroids among athletes and bodybuilders are contributing to fertility issues, fueling demand for corrective treatments. Also, research institutions are actively investing in genetic testing to address unexplained infertility cases which is bolstering the market growth. Meanwhile, the growing social acceptance of discussing male reproductive health is encouraging more individuals to seek timely medical intervention. This, in turn, is impelling the market growth.

Asia Pacific Male Infertility Market Analysis

The male infertility market in Asia Pacific is witnessing progress with the adoption of cost-effective in-vitro fertilization procedures appropriate for middle-income families. Besides this, governments are promoting awareness campaigns emphasizing the evaluation of male fertility, as the stigma surrounding infertility places blame on women. With increasing environmental toxins and industrial pollutants in urban areas, which have been proven to decrease sperm quality, demand is building for therapeutic solutions. According to reports, in 2019, India ranked as the fifth most polluted country globally and accounted for 14 of the 20 cities with the highest PM 2.5 air pollution levels. Furthermore, the rise of medical tourism, particularly in countries such as India and Thailand, is making advanced fertility treatments accessible at competitive prices, thereby positively influencing the market.

Europe Male Infertility Market Analysis

In Europe, the market is changing with the implementation of stringent workplace health regulations to limit exposure to reproductive toxins. As per the male infertility market report, pharmaceutical companies are rolling out new medications addressing hormonal imbalances linked to infertility, supported by favorable regulatory frameworks. Additionally, lifestyle shifts, including delayed family planning and increased alcohol consumption, are escalating infertility rates, prompting a rise in medical consultations. According to the government of the UK, in 2022, 56% of adults in England consumed alcohol. Moreover, men drank more than that of women. 61% of men and 51% of women consumed alcohol across the country. Apart from this, fertility centers are using non-invasive diagnostic techniques such as high-resolution ultrasound that are patient-friendly and, therefore, act as a catalyst in the market expansion. In addition, governments in the region are funding research in cryopreservation technologies that are currently in vogue among men who delay parenting. With these factors at play, the demand in the market is going up in the region.

Latin America Male Infertility Market Analysis

The Latin America male infertility market is expanding with the rising demand for low-cost fertility treatments, making them accessible to a broader population. Moreover, increased pesticide and agrochemical exposure in rural areas is driving awareness and treatment for sperm-related issues. Furthermore, rapid urbanization is contributing to lifestyle-related fertility challenges, prompting the adoption of personalized fertility solutions. According to the Central Intelligence Agency, in 2021, 87.3% of the total population in Brazil is urbanized. Due to these, the demand for male infertility market is expanding across the region.

Middle East and Africa Male Infertility Market Analysis

The Middle East and Africa market for male fertility is growing as the socio-cultural factors that created barriers to talking about infertility are slowly coming down. The rising incidences of varicocele, which were not always diagnosed due to ignorance regarding the symptoms, are being treated through minimally invasive surgery. Climatic conditions with extreme heat also resulted in low sperm quality, leading to increased demand for sophisticated diagnostic solutions. According to the NASA Earth Observatory, on June 6, 2021, Sweihan in the UAE recorded a temperature of 51.8°C (125.2°F), marking the highest temperature ever documented in the country for the month of June.

Competitive Landscape:

According to male infertility market report, the leading players are investing in research and development (R&D) to design new and enhanced diagnostic tools, treatments, and technologies for male infertility. The innovation is focused on techniques of sperm analysis, new medication, and assisted reproductive technology to ensure improved results for the treatment. Some leading players usually engage academic institutes, research institutions, and healthcare providers to share ideas and experiences with one another in their bid to enable innovations in diagnostics and treatments for male infertility. These collaborations inspire synergistic efforts to solve complex issues with the provision of holistic solutions. In addition to this, as raising awareness about male infertility becomes important, industry leaders participate in educational activities. Online platforms, seminars, and health care professional training sessions serve as information provision mediums for them. Thus, they work toward understanding the condition and ensure appropriate interventions at the right time. Moreover, key players are involved in strategic expansion endeavors by tapping into emerging markets having rising demand for the treatment of male infertility. While expanding their reach, they ensure that a larger section of patients can access leading diagnostic and therapeutic facilities.

The report provides a comprehensive analysis of the competitive landscape in the male infertility market with detailed profiles of all major companies, including:

  • Andrology Solutions
  • CaerusBiotech
  • CinnaGen Co.
  • Ferring group of companies
  • Halotech DNA
  • Merck KGaA
  • MotilityCount
  • SCSA Diagnostics, Inc
  • Vitrolife
  • Zydus Healthcare Limited

Key Questions Answered in This Report

  • 1.How big is the male infertility market?
  • 2.What is the future outlook of the male infertility market?
  • 3.What are the key factors driving the global male infertility market?
  • 4.Which region accounts for the largest male infertility market share?
  • 5.Which are the leading companies in the global male infertility market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Male Infertility Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Sperm Agglutination
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DNA Fragmentation Technique
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidative Stress Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Computer Assisted Semen Analysis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Sperm Penetration Assay
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Treatment

  • 7.1 Medication
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Assisted Reproductive Technology and Varicocele Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Fertility Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Andrology Solutions
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CaerusBiotech
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 CinnaGen Co.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Ferring group of companies
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Halotech DNA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 MotilityCount
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 SCSA Diagnostics, Inc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Vitrolife
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Zydus Healthcare Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Male Infertility Market: Major Drivers and Challenges
  • Figure 2: Global: Male Infertility Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Male Infertility Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Male Infertility Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Male Infertility Market: Breakup by Treatment (in %), 2025
  • Figure 6: Global: Male Infertility Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Male Infertility Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Male Infertility Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Male Infertility (Sperm Agglutination) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Male Infertility (Sperm Agglutination) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Male Infertility (DNA Fragmentation Technique) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Male Infertility (DNA Fragmentation Technique) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Male Infertility (Oxidative Stress Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Male Infertility (Oxidative Stress Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Male Infertility (Computer Assisted Semen Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Male Infertility (Computer Assisted Semen Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Male Infertility (Sperm Penetration Assay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Male Infertility (Sperm Penetration Assay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Male Infertility (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Male Infertility (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Male Infertility (Medication) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Male Infertility (Medication) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Male Infertility (Assisted Reproductive Technology and Varicocele Surgery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Male Infertility (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Male Infertility (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Male Infertility (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Male Infertility (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Male Infertility (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Male Infertility (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Male Infertility (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Male Infertility (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Male Infertility (Fertility Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Male Infertility (Fertility Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Male Infertility (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Male Infertility (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Male Infertility (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Male Infertility (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: North America: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: North America: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: United States: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: United States: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Canada: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Canada: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia-Pacific: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Asia-Pacific: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: China: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: China: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Japan: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Japan: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: India: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: India: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: South Korea: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: South Korea: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Australia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Australia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Indonesia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Indonesia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Europe: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Europe: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Germany: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Germany: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: France: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: France: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: United Kingdom: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: United Kingdom: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Italy: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Italy: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Spain: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Spain: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Russia: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Russia: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Latin America: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Latin America: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Brazil: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Brazil: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Mexico: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Mexico: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Middle East and Africa: Male Infertility Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Middle East and Africa: Male Infertility Market: Breakup by Country (in %), 2025
  • Figure 87: Middle East and Africa: Male Infertility Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Male Infertility Industry: SWOT Analysis
  • Figure 89: Global: Male Infertility Industry: Value Chain Analysis
  • Figure 90: Global: Male Infertility Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Male Infertility Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Male Infertility Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Male Infertility Market Forecast: Breakup by Treatment (in Million USD), 2026-2034
  • Table 4: Global: Male Infertility Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Male Infertility Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Male Infertility Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Male Infertility Market: Competitive Structure
  • Table 8: Global: Male Infertility Market: Key Players